Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy

Kim Henriksen; Inger Byrjalsen; Per Qvist; Henning Beck-Nielsen; Gitte Hansen; Bente J. Riis; Hans Perrild; Ole Lander Svendsen; Jeppe Gram; Morten A. Karsdal; Claus Christiansen;

doi:10.1002/dmrr.1187

Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.1187 ◽

2011 ◽

Vol 27 (4) ◽

pp. 392-401 ◽

Cited By ~ 48

Author(s):

Kim Henriksen ◽

Inger Byrjalsen ◽

Per Qvist ◽

Henning Beck-Nielsen ◽

Gitte Hansen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Partial Agonist ◽

Phase Iii ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Efficacy and Safety of the Partial PPARγ Agonist Balaglitazone Compared with Pioglitazone and Placebo: A Phase III, Randomized, Parallel-Group Study in Patients with Type 2 Diabetes on Stable Insulin Therapy

10.1210/endo-meetings.2011.part4.p4.p3-467 ◽

2011 ◽

pp. P3-467-P3-467

Author(s):

Kim Henriksen ◽

Inger Byrjalsen ◽

Per Qvist ◽

Henning Beck-Nielsen ◽

Gitte Hansen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group ◽

Pparγ Agonist

Download Full-text

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin

Diabetes Care ◽

10.2337/dc05-1880 ◽

2006 ◽

Vol 29 (8) ◽

pp. 1818-1825 ◽

Cited By ~ 41

Author(s):

A. H. Barnett ◽

M. Dreyer ◽

P. Lange ◽

M. Serdarevic-Pehar ◽

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Safety Profile ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Comparison of Efficacy and Safety of Hydroxychloroquine and Teneligliptin in Type 2 Diabetes Patients who are Inadequately Controlled with Glimepiride, Metformin and Insulin therapy: A Randomized Controlled Trial with Parallel Group Design

10.29328/journal.acem.1001009 ◽

2017 ◽

Vol 2 (1) ◽

pp. 033-040 ◽

Cited By ~ 2

Author(s):

Ahsan Sajjad

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Therapy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Group Design ◽

Randomized Controlled ◽

Parallel Group Design ◽

Parallel Group

Download Full-text

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Meformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea: Response to Mikhail and Cope

Diabetes Care ◽

10.2337/dc-06-1466 ◽

2006 ◽

Vol 29 (10) ◽

pp. 2333-2334 ◽

Cited By ~ 1

Author(s):

A. H. Barnett ◽

M. Dreyer ◽

P. Lange ◽

M. Serdarevic-Pehar ◽

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Safety Profile ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin: Response to Kanna and Abreu-Pacheco

Diabetes Care ◽

10.2337/dc06-2173 ◽

2007 ◽

Vol 30 (2) ◽

pp. 446-446

Author(s):

A. H. Barnett ◽

M. Dreyer ◽

P. Lange ◽

M. Serdarevic-Pehar ◽

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Safety Profile ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: Results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study

Clinical Therapeutics ◽

10.1016/j.clinthera.2005.05.005 ◽

2005 ◽

Vol 27 (5) ◽

pp. 554-567 ◽

Cited By ~ 70

Author(s):

Vinod Mattoo ◽

David Eckland ◽

Mario Widel ◽

Santiago Duran ◽

Carmen Fajardo ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Therapy ◽

Metabolic Effects ◽

Double Blind ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin: Response to Barnett et al.

Diabetes Care ◽

10.2337/dc06-2031 ◽

2007 ◽

Vol 30 (2) ◽

pp. 445-446 ◽

Cited By ~ 1

Author(s):

B. Kanna ◽

H. Abreu-Pacheco

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Safety Profile ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

Clinical Therapeutics ◽

10.1016/j.clinthera.2006.10.007 ◽

2006 ◽

Vol 28 (10) ◽

pp. 1556-1568 ◽

Cited By ~ 354

Author(s):

Julio Rosenstock ◽

Ronald Brazg ◽

Paula J. Andryuk ◽

Kaifeng Lu ◽

Peter Stein

Keyword(s):

Type 2 Diabetes ◽

Dipeptidyl Peptidase ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Dipeptidyl Peptidase 4 ◽

Parallel Group Study ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Parallel Group

Download Full-text

Efficacy and Safety of Empagliflozin Monotherapy for 52 Weeks in Japanese Patients with Type 2 Diabetes: A Randomized, Double-Blind, Parallel-Group Study

Advances in Therapy ◽

10.1007/s12325-015-0198-0 ◽

2015 ◽

Vol 32 (4) ◽

pp. 306-318 ◽

Cited By ~ 27

Author(s):

Takashi Kadowaki ◽

Masakazu Haneda ◽

Nobuya Inagaki ◽

Yasuo Terauchi ◽

Atsushi Taniguchi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Meformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea: Response to Barnett et al.

Diabetes Care ◽

10.2337/dc06-1316 ◽

2006 ◽

Vol 29 (10) ◽

pp. 2332-2333

Author(s):

N. Mikhail ◽

D. Cope

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Safety Profile ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group

Download Full-text